Otolaryngology Doctors in Omaha, NE Accepting Medicare

65 Otolaryngology doctors found. Showing 61 - 65

Dr. Rodney P Lusk, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 555 N 30th St, Omaha, NE 68131 Phone: 402-498-6540    Fax: 402-498-6357

Christie Annne Barnes, MD,MS Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: Emile 42nd St, Omaha, NE 68198 Phone: 402-559-1700    Fax: 402-559-8940

Dr. Brynn Elaina Richardson, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 981225 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-7777    Fax: 402-559-8940

Kyle Jonathan Stansifer, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 720 N 129th St, Omaha, NE 68154 Phone: 402-397-0670

Andrew William Logeman, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4400 Emile St, Omaha, NE 68198 Phone: 402-559-6329

News Archive

Karolinska Institutet researchers contribute at ESOF 2010

Researchers and staff from Karolinska Institutet are contributing to Europe's largest cross-disciplinary gathering place with news of everything from neuroscience to bioentrepreneurship. Carl Johan Sundberg, university lecturer and associate professor at Karolinska Institutet, is the founder and initiator of ESOF.

Doctors receive €3.5M European Union funding to diagnose, treat balance disorders

GPs and other doctors will be equipped with a new, online information system to help diagnose and treat a range of balance disorders, thanks to €3.5m European Union funding for EMBalance.

Obama faces trust issues as a result of health law woes

President Barack Obama - and Democrats, by proxy - face big political problems as a result of the botched rollout of the insurance website and the debunking of his pledge that Americans could keep their health plans if they liked them. Recent polls have Democrats and Republicans neck-and-neck in midterm election polls, and Fox News reports that half of voters think the president "knowingly lied" about the health law.

AFFiRiS releases positive study results of AD04 therapeutic drug in Alzheimer patients

AFFiRiS announced today the results of a phase II study in Alzheimer patients. AFFiRiS' proprietary compound AD04 is the first drug ever to demonstrate clinical and biomarker effects consistent with disease modification in Alzheimer patients.

Read more Medical News

› Verified 7 days ago

• 1
• 2
• 3
• 4(current)